Q4 2024 Earnings Call Transcript March 11, 2025 Agenus Inc. beats earnings expectations. Reported EPS is $-2.04, expectations ...

Agenus Inc (AGEN) reports reduced operational burn and promising clinical developments, despite a significant net loss and ...

Baird lowered the firm’s price target on Agenus (AGEN) to $3 from $6 and keeps a Neutral rating on the shares. The firm updated its model ...

Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. I will now turn the call ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.